Delivery Order SPE2DB20D3104-SPE2DB25FV9Q8
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Corlanor 5 mg tablets (60-count) with a ceiling value of $3,296.56. This firm fixed price delivery order, with an ultimate completion date of August 13, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract was...
- The Defense Logistics Agency awarded a $3,989.52 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Corlanor 5 mg, with an ultimate completion date of July 28, 2025. This is a firm fixed price, non-set-aside contract classified as a child award, indicating it derives from a larger contract vehicle. The pharmaceutical product will be delivered to the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for CORLANOR 5 MG tablets (60-count packages) with a ceiling value of $38,930.45. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The order is scheduled for completion by July 28, 2025, with performance at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $1,549.52 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Corlanor 5 mg tablets (60-count). This is a non-set-aside contract with an ultimate completion date of August 18, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $4,615.05 to AmerisourceBergen Drug Corp for Corlanor 7.5 mg tablets (60-count units) on August 5, 2025, with completion expected by August 6, 2025. This competitively awarded, firm fixed-price contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken,...
- This is a $1,735.54 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is to supply CORLANOR 5 MG TABLET 60S, a cardiovascular medication, with a performance period through March 2025. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive...
- The Defense Logistics Agency awarded a $2,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 60 tablets of Corlanor 5 mg to be delivered to a location in Conshohocken, Pennsylvania between August 3rd and August 4th, 2023. Corlanor is a medication used for the treatment of chronic heart failure. As a leading provider of pharmaceuticals and medical supplies, Amerisourcebergen will fulfill this order from the Defense Logistics Agency, the logistics combat support agency...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of CORLANOR 5 MG TABLET 60S, a medication used in the treatment of heart conditions. The contract has a ceiling value of $1,551.62 and runs through January 6, 2025. It is a firm-fixed-price contract and was not set aside for any specific business type. AmerisourceBergen holds a significant...
- The Defense Logistics Agency awarded a $3,310.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Corlanor 5 mg, with an ultimate completion date of August 18, 2025. This non-set-aside contract was competitively awarded on August 15, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $1,642.24 to AmerisourceBergen Drug Corp for the supply of Corlanor 5 mg tablets (60-count) on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. The contract represents a routine pharmaceutical procurement supporting federal medical supply needs...
- SPE2DB20D3104Indefinite Delivery Contract
- SPE2DB20D3104-SPE2DB25FV9Q8Delivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,020.71 for CORLANOR 5 mg tablets (60-count units) on August 19, 2025, with an ultimate completion date of August 20, 2025. This non-set-aside, competitively awarded contract reflects a firm fixed price delivery order structure and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. CORLANOR (ivabradine) is a heart rate-reducing medication primarily used in the treatment of chronic heart failure and represents one of many pharmaceutical products AmerisourceBergen supplies through federal channels. This delivery order is a child contract issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical, a $999.99 billion prime vendor agreement (designated SPE2DX) extending through December 2026 that enables the company to supply comprehensive pharmaceutical and medical commodities globally to support military healthcare programs. AmerisourceBergen's significant federal pharmaceutical distribution portfolio demonstrates its established capability to meet the Defense Logistics Agency's medical supply requirements across multiple therapeutic domains, serving customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 8/19/25 |